Relationship between inflammation and the severity of Recurrent Respiratory Papillomatosis
Introduction
Recurrent Respiratory Papillomatosis (RRP) is a serious disease that occurs in two clinical forms: juvenile (JRRP) and adult (ARRP); the former occurs predominantly before 5 years of age and affects both females and males equally; the latter is prevalent in male patients between 20 and 40 years of age [1].
Human papillomavirus (HPV) infection is responsible for the development of the disease, primarily the low-risk types HPV 6 and 11 [1,2]. HPV type 6 is the most common [3,4] and type 11 is predominant in the most aggressive cases [1,5].
There are scales that assist in therapeutic decision-making and in the identification of aggressive cases, including: Voice Handicap Index-10 (VHI-10) [6], Roughness, Breathiness, Asthenia, Strain (GRBAS) [7] and the laryngoscopic scale of Derkay et al. (1998) [8].
The immune system is important in preventing lesion progression and encouraging HPV-infection clearance [9]. There are few studies correlating the aggressiveness of RRP to inflammation and the results are not uniform [10,11]. The severity of RRP has been correlated with greater numbers of CD83+ mature dendritic cells (DC) in the epithelium and there is evidence of the involvement of migration of these cells and their retention in the epithelial layer [11]. In RRP, the imbalance between Th1 and Th2 immune responses may contribute to the persistence of infection and recurrence of this disease [10].
Noting the important role of inflammation, or its absence, related to the above-mentioned disease, the present study aims to identify possible differences in the population of inflammatory cells secreting pro-inflammatory cytokines and chemokines between patients with low and high Derkay indexes.
The results may detect prognostic factors that lead to the early recognition of aggressive cases, and also determine possible causes that lead to the varied behavior of this disease that may occur in isolated cases, multiple relapses or spontaneous remission.
Section snippets
Samples
Retrospective samples of JRRP and ARRP were collected at different centers: 3 samples from the Pediatric Otorhinolaryngology Outpatient Clinic of the Paulista Medical School/UNIFESP; 70 from the Ribeirão Preto Medical School/USP and 19 from the Head and Neck Clinical Center in Guatemala. A total of 36 juvenile samples and 56 adults' samples were used, of which 46 were from Brazil and 10 from Guatemala, and the sampling period was from 1997 to 2016. The Research Ethical Committee of the São
Clinical findings
From the clinical data, for the juvenile group, the mean age was 4.94 years, ranging from 1 to 15 years, with 18 (50.00%) cases in males and 18 (50.00%) in females (ratio of 1:1). Additionally, 6 (16.67%) patients received some adjuvant treatment and 1 (2.78%) patient was receiving treatment for asthma, and 6 (18.18%) required tracheostomy.
The mean age of the adult group was 41.62 years, ranging from 19 to 74 years of age; 24 (50%) patients were over 40 years old, with 41 (73.21%) cases in
Discussion
RRP is an uncommon disease that can develop a severe clinical course leading to death [1,18]. Such aggressiveness is related to age, time of evolution and type of HPV [19,20]. Additionally, the immune system may also play an important role in the clinical course of the disease [11].
CD3+ T cells represents the total number of T lymphocytes [17]. In the present study, these cells were present in greater numbers in adult patients; the group that presented less severe RRP. CD3+ T cells are
Conclusion
In summary, our results found a correlation of CD3+ and CD8+ cells with low-grade dysplasia and CD68+ with high-grade dysplasia. In more severe cases of JRRP, a smaller quantity of CD3+, CD8+ and MUM1+ cells was observed. The immune system imbalance can play an important role in the severity of RRP.
Funding
For the financial support received from FAPESP (São Paulo Research Foundation, Grant: 16/24019-0 to EK) and CAPES (Coordination for the Improvement of Higher Education Personnel to VNREA).
Declaration of competing interest
All the authors declare that there is no conflict of interest.
References (35)
- et al.
Photoangiolytic laser treatment of recurrent respiratory papillomatosis: a scaled assessment
J Voice
(2013) - et al.
Distribution and density of CD1a+ and CD83+ dendritic cells in HPV-associated laryngeal papillomas
Int J Pediatr Otorhinolaryngol
(2009) - et al.
Reliability of a staging assessment system for recurrent respiratory papillomatosis
Int J Pediatr Otorhinolaryngol
(2003) - et al.
Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance
Clin Immunol
(1999) - et al.
Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis
Mol Immunol
(2018) - et al.
CD4+ CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids
Clin Immunol
(2008) - et al.
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
Trends Immunol
(2002) - et al.
A single human papillomavirus vaccine dose improves B cell memory in previously infected subjects
EBioMedicine
(2016) - et al.
Squamous cell papilloma and squamous cell papilomatosis
- et al.
Laryngeal Papillomatosis associated dysplasia in the adult population: an update on prevalence and HPV subtyping
Ann Otol Rhinol Laryngol
(2014)
Replicative intermediates of human papillomavirus type 11 in laryngeal papillomas: site of replication initiation and direction of replication
Proc Natl Acad Sci U S A
Increased p50/p50 NF-KB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue
J Virol
Association of human papillomavirus subtype and clinical course in respiratory papillomatosis
Laryngoscope
Development and validation of the voice handicap index-10
Laryngoscope
A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis
Laryngoscope
Local and systemic immunomodulatory mechanisms triggered by human papillomavirus transformed cells: a potential role for G-CSF and neutrophils
Sci Rep
Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis
Mol Med
Cited by (4)
Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study
2023, Acta Otorhinolaryngologica ItalicaImmune delineation of laryngeal papilloma reveals enhanced neutrophil associated gene profile
2021, European Journal of ImmunologyDistribution Characteristics of Juvenile-Onset Recurrent Respiratory Papillomatosis at First-Time Surgery
2021, Ear, Nose and Throat Journal